Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Jun. 30, 2023
Cash Flows from Operating Activities
Net loss	$ (28,475)	$ (67,534)	$ (45,072)	$ (38,698)	$ (96,009)	$ (83,770)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation					132,210	129,227
Amortization					144,168	187,968
Share-based compensation expense					72,465	88,952
Amortization of discount on convertible debt and debt issuance costs					8,803	8,276
Non-cash restructuring charges					2,639	0
Loss on disposal of property, plant and equipment					238	0
Unrealized (gains) losses on foreign currency remeasurements and transactions					(1,835)	3,988
Loss (earnings) from equity investments					301	(740)
Deferred income taxes					(96,683)	(86,232)
Loss on debt extinguishment					0	6,835
Increase (decrease) in cash from changes in (net of effect of acquisitions):
Accounts receivable					53,428	12,647
Inventories					(3,164)	96,084
Accounts payable					62,998	(82,042)
Contract liabilities					(31,451)	12,078
Income taxes					26,877	24,098
Accrued compensation and benefits					11,175	(24,231)
Other operating assets and liabilities					(20,189)	6,930
Net cash provided by operating activities					265,971	300,068
Cash Flows from Investing Activities
Additions to property, plant & equipment					(153,667)	(245,854)
Purchases of businesses, net of cash acquired					0	(5,488,556)
Other investing activities					(1,978)	(2,261)
Net cash used in investing activities					(155,645)	(5,736,671)
Cash Flows from Financing Activities
Sale of shares to noncontrolling interests					1,000,000	0
Proceeds from borrowings of Revolving Credit Facility					0	65,000
Payments on existing debt					(107,457)	(1,065,217)
Payments on borrowings under Revolving Credit Facility					0	(65,000)
Payments on convertible notes					0	(3,561)
Debt issuance costs					0	(126,516)
Equity issuance costs					(31,840)	(42,000)
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan					16,143	7,749
Payments in satisfaction of employees' minimum tax obligations					(17,566)	(50,516)
Cash dividends paid					0	(13,800)
Other financing activities					(531)	(582)
Net cash provided by financing activities					858,749	3,755,557
Effect of exchange rate changes on cash, cash equivalents, and restricted cash					14,049	16,769
Net increase (decrease) in cash, cash equivalents, and restricted cash					983,124	(1,664,277)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period		$ 837,566		$ 2,582,371	837,566	2,582,371	$ 2,582,371
Cash, Cash Equivalents, and Restricted Cash at End of Period	1,820,690		918,094		1,820,690	918,094	837,566
Supplemental Information
Cash paid for interest					159,538	127,039
Cash paid for income taxes					38,142	31,853
Additions to property, plant & equipment included in accounts payable					71,806	47,060
Non-Cash Investing and Financing Activities
Conversion of Series A preferred stock to common stock					445,319	0
Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Restricted cash, current	964,000				964,000		16,000
Cash and cash equivalents	856,255		896,641		856,255	896,641	821,310
Restricted cash, current	177,077		16,645		177,077	16,645
Restricted cash, non-current	787,358		4,808		787,358	4,808
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$ 1,820,690		$ 918,094		1,820,690	918,094	$ 837,566
Series B Preferred Shares
Cash Flows from Financing Activities
Proceeds from issuance of Series B Preferred Shares					0	1,400,000
Term A Loan
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility					0	850,000
Term B Loan
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility					$ 0	$ 2,800,000